it is a pan-agonist for peroxisome proliferator-activated receptor(PPAR), a antilipemic agent that lowers cholestrol and triglycerides.
Causes expression of an increased number of specific LDL receptors and hence increased catabolism of LDL. Also it leads to increase catabolism of triglycerides and decreases endogenous synthesis, leading to reduced triglyceride plasma levels.
Causes expression of an increased number of specific LDL receptors and hence increased catabolism of LDL. Also it leads to increase catabolism of triglycerides and decreases endogenous synthesis, leading to reduced triglyceride plasma levels.
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2025 The Doctors Platform. All Right Reserved.
